Braveheart Investment (BRH) AI Stock Analysis

• Market Cap: £1.80M
• Dividend Yield: N/A
• Average Volume (3M): 82.09K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.00
• Revenue Growth: 502.47%
• EPS Growth: -501.58%
• Country: UK
• Employees: 5
• Sector: Financial
• Sector Strength: 81
• Industry: Asset Management
• EPS (TTM): <0.01
• Shares Outstanding: 78,473,490
• 10 Day Avg. Volume: 63,738
• 30 Day Avg. Volume: 82,086
• PEG Ratio: -0.19
• Price to Book (P/B): 0.38
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -5.19
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 43 Neutral
• Price Target: ―

Braveheart Investment Group faces significant financial instability, marked by declining revenues and profitability issues, despite having no debt. Technical analysis indicates a bearish trend, with the stock trading below key moving averages and being oversold. Valuation metrics are unattractive due to a negative P/E ratio and no dividend yield. However, the recent strategic investment in IQ-AI Ltd is a positive development that might enhance its market position, but overall risks remain high.

Braveheart Investment Business Overview & Revenue Model

Company Description

Braveheart Investment (BRH) is a prominent investment management firm specializing in providing innovative financial solutions and investment opportunities across various sectors such as technology, healthcare, and renewable energy. The company offers a range of services including asset management, venture capital, and financial advisory services, catering to both institutional and individual investors seeking to optimize their investment portfolios.

How the Company Makes Money

Braveheart Investment makes money primarily through management fees and performance fees associated with its asset management services. These fees are charged to clients based on the assets under management (AUM) and the performance of the investment portfolio. Additionally, the company generates revenue from its venture capital activities by investing in high-growth potential startups and earning returns on these investments. Financial advisory services also contribute to the company's earnings through consultancy fees. Strategic partnerships with financial institutions and co-investment opportunities further enhance Braveheart Investment's revenue streams by expanding its reach and leveraging shared resources.

Braveheart Investment Financial Statement Overview

Summary

Braveheart Investment exhibits financial instability with declining revenues and profitability issues. Despite a strong equity standing and no debt, cash flow inefficiencies and declining assets present significant financial challenges.

Income Statement

The income statement reveals significant volatility with a decline in revenue from 2021 to 2023, alongside negative net income in the most recent year. The company experienced a dramatic revenue drop after 2021, with a growth rate of 2579.88% in 2023 followed by a decline in 2024, indicating instability. The gross profit margin improved to 68.67% in 2024, but the net profit margin was negative at -531.16%, highlighting profitability challenges.

Balance Sheet

The balance sheet shows a strong equity position with no debt, improving the debt-to-equity ratio to 0. The equity ratio is robust at 97.04%, indicating financial stability. However, a significant decline in total assets over the years raises concerns about asset management.

Cash Flow

Cash flow analysis shows a negative operating cash flow and free cash flow, coupled with no financing activities, indicating liquidity issues. The free cash flow to net income ratio is also negative, reflecting cash flow inefficiencies.

Breakdown	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Income Statement
Total Revenue	60.90K	50.90K	78.13K	7.85M	443.55K
Gross Profit	-366.56K	-505.24K	-558.01K	7.06M	87.74K
EBITDA	-811.88K	-788.22K	-695.49K	5.28M	-371.80K
Net Income	-7.25M	1.58M	1.45M	13.94M	-575.53K
Balance Sheet
Total Assets	3.50M	11.61M	7.06M	3.20M	2.08M
Cash, Cash Equivalents and Short-Term Investments	1.74M	934.86K	1.89M	2.14M	684.89K
Total Debt	0.00	0.00	0.00	13.18K	22.02K
Total Liabilities	104.14K	1.09M	449.86K	632.92K	302.70K
Stockholders Equity	3.40M	10.52M	6.63M	2.57M	1.70M
Cash Flow
Free Cash Flow	-736.12K	-768.19K	-1.28M	-1.29M	-369.20K
Operating Cash Flow	-736.12K	-768.19K	-1.27M	-1.28M	-352.20K
Investing Cash Flow	1.54M	-1.08M	-1.40M	17.09M	-34.78K
Financing Cash Flow	0.00	930.36K	2.42M	-14.35M	-135.41K

Braveheart Investment Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 2.30
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Positive
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:BRH, the sentiment is Negative. The current price of 2.3 is below the 20-day moving average (MA) of 2.33, below the 50-day MA of 2.83, and below the 200-day MA of 4.11, indicating a bearish trend. The MACD of -0.13 indicates Negative momentum. The RSI at 11.22 is Positive, neither overbought nor oversold. The STOCH value of 77.27 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:BRH.

Braveheart Investment Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
AIE	79 Outperform		4.64	21.58%	―	52.96%	30.01%
HICL	73 Outperform		51.23	1.47%	7.09%	-3.67%	51.49%
PHI	66 Neutral		7.62	12.49%	0.43%	―	―
Sector *	64 Neutral	$6.55B	10.89	6.59%	5.08%	24.65%	0.99%
GROW	52 Neutral	£561.69M	10,666.67	-0.06%	―	59.93%	97.07%
BRH	43 Neutral	£1.80M	―	-97.45%	―	502.47%	-501.58%

Braveheart Investment Corporate Events

Braveheart Investment Group Expands Stake in IQ-AI Ltd

Braveheart Investment Group plc has increased its stake in IQ-AI Ltd by subscribing to 7,000,000 new shares in a recent placing, raising its holding to 29.35% of IQ-AI’s enlarged share capital. This strategic investment is seen as a significant addition to Braveheart’s portfolio, potentially enhancing its market position and offering stakeholders increased value through IQ-AI’s innovative imaging platforms and therapeutics.